Inventaire - teman dan komunitas anda adalah perpustakaan terbaik

Interpretation and use of FRAX in clinical practice

pengarang

Cyrus Cooper

2000 -

Jane A. Cauley

1950 -

William D. Leslie

diterbitkan dalam: Osteoporosis International

tanggal publikasi: 2011-07-21

bahasa: Inggris

Cites articles 104

Date

Judul

Pengarang

2012-06-01

Does osteoporosis therapy invalidate FRAX for fracture prediction?

William D. Leslie, Eugene V McCloskey, Anders Odén, John Kanis, Helena Johansson, Manitoba Bone Density Program
2011-01-17

Screening for osteoporosis: U.S. preventive services task force recommendation statement

United States Preventive Services Task Force
2011-01-13

Guidance for the adjustment of FRAX according to the dose of glucocorticoids
2011-04-02

Secular trends in the incidence of hip and other osteoporotic fractures

Cyrus Cooper, Nicholas C Harvey, Elaine Dennison, L. Joseph Melton
2011-07-01

Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®). Executive Summary of the 2010 Position Development Conference on Interpretation and use of FRAX® in clinical practi

Bess Dawson-Hughes, William D. Leslie, Jane A. Cauley, Cyrus Cooper, John P. Bilezikian, Eugene V McCloskey, John Kanis, Juliet Compston, Neil Binkley, E Michael Lewiecki, Marjorie M Luckey, Socrates E Papapoulos, FRAX(®) Position Development Conference Members
2011-07-01

Official Positions for FRAX® clinical regarding rheumatoid arthritis from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.
2011-07-01

Official Positions for FRAX® clinical regarding falls and frailty: can falls and frailty be used in FRAX®? From Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Fou

Marian T Hannan
2011-07

Official Positions for FRAX® Clinical Regarding Glucocorticoids: The Impact of the Use of Glucocorticoids on the Estimate by FRAX® of the 10 Year Risk of Fracture

Eugene V McCloskey
2011-07-01

Official Positions for FRAX® clinical regarding prior fractures from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®

Robert D Blank
2011-07-01

Official Positions for FRAX® clinical regarding smoking from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.
2011-07-01

Official Positions for FRAX® clinical regarding international differences from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.

Rola El Rassi, Olga Lesnyak, Wojciech Pluskiewicz, Anne-Marie Schott, Jane A. Cauley, Jeffrey R Curtis, Saeko Fujiwara
2011-01-13

New considerations on the management of osteoporosis in Central and Eastern Europe (CEE): summary of the "3rd Summit on Osteoporosis-CEE", November 2009, Budapest, Hungary

Vladimir Palicka, Jan J. Štěpán, Roman S Lorenc
2011-04-02

Ethnic difference of clinical vertebral fracture risk
2010-07-26

American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis

Jeffrey R Curtis
2010-11-23

2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary

Suzanne N Morin, Angela M. Cheung, William D. Leslie
2010-03-30

A FRAX® model for the assessment of fracture probability in Belgium.
2010-02-27

Severity of vertebral fracture and risk of hip fracture: a nested case-control study

Ilkka J Helenius
2010-10-20

Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis
2010-04-27

World Health Organization fracture risk assessment tool in the assessment of fractures after falls in hospital
2010-12-24

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards

Michael McClung, Cyrus Cooper, Richard Eastell, Olivier Bruyere
2010-10-20

Spine-hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement.

William D. Leslie
2010-01-20

Interventions for preventing falls in older people in nursing care facilities and hospitals

Robert G Cumming, Ngaire Kerse
2009-11-19

Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores

Carol Coupland, Julia Hippisley-Cox
2009-02-03

FRAX and its applications to clinical practice

Eugene V McCloskey, Anders Odén, John Kanis, Helena Johansson
2009-01-08

Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK.
2009-10-09

Bone mineral density and fractures in older men with chronic obstructive pulmonary disease or asthma

Elizabeth Barrett-Connor
2009-05-13

Can fall risk be incorporated into fracture risk assessment algorithms: a pilot study of responsiveness to clodronate
2009-10-01

Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials

Douglas P. Kiel, Heike A Bischoff-Ferrari
2009-01-01

Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club
2009-04-10

Bone turnover markers in the management of postmenopausal osteoporosis

Suzanne N Morin
2009-12-09

Epidemiology of hip fracture in Tucuman, Argentina.
2009-08-25

The effects of a FRAX revision for the USA.

L. Joseph Melton

Artikel - wd:Q37903748

Selamat datang di Inventaire

perpustakaan teman-teman dan komunitas anda

pelajari lebih lanjut